Systematic Financial Management LP Biogen Inc. Transaction History

Systematic Financial Management LP

$3.17 Billion
Q2 2024

A detailed history of Systematic Financial Management LP transactions in Biogen Inc. stock. As of the latest transaction made, Systematic Financial Management LP holds 4,670 shares of BIIB stock, worth $913,592. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,670

Previous 4,160 12.26%

Holding current value

$913,592

Previous $897,000 20.62%

% of portfolio

0.03%

Previous 0.03%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$190.52 - $236.72 $97,165 - $120,727	510 Added 12.26%	4,670 $1.08 Million
Q1 2024 May 14, 2024	BUY	$212.02 - $267.71 $530,050 - $669,275	2,500 Added 150.6%	4,160 $897,000
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $4,451 - $5,358	20 Added 1.22%	1,660 $429,000
Q1 2023 May 12, 2023	BUY	$256.56 - $292.34 $10,262 - $11,693	40 Added 2.5%	1,640 $455,000
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $11,443 - $15,811	-52 Reduced 3.15%	1,600 $475,000
Q3 2019 Nov 06, 2019	SELL	$217.44 - $243.88 $617,312 - $692,375	-2,839 Reduced 63.22%	1,652 $385,000
Q2 2019 Jul 26, 2019	SELL	$219.29 - $241.72 $120,390 - $132,704	-549 Reduced 10.89%	4,491 $1.05 Million
Q1 2019 May 03, 2019	SELL	$216.71 - $338.96 $121,357 - $189,817	-560 Reduced 10.0%	5,040 $1.19 Million
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $198,013 - $250,805	-711 Reduced 11.27%	5,600 $1.69 Million
Q3 2018 Nov 06, 2018	BUY	$293.51 - $383.83 $1.38 Million - $1.81 Million	4,711 Added 294.44%	6,311 $2.23 Million
Q3 2017 Nov 08, 2017	BUY	$281.15 - $329.69 $449,839 - $527,504	1,600	1,600 $501,000

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Systematic Financial Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Systematic Financial Management LP with notifications on news.

Account

Systematic Financial Management LP Biogen Inc. Transaction History